Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Shrink Nanotechnologies, a company into developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology R&D tools businesses, has filed patent applications for its stem cell research and drug discovery tool StemDisc.
Subscribe to our email newsletter
StemDisc is Shrink’s latest bioscience application of its proprietary, patent-pending, advanced plastic material called NanoShrink.
Shrink has claimed that StemDisc offers a low cost, flexible and cost effective solution for biotech researchers to conduct experiments for drug discovery, regenerative medicine and cancer research, among others.
Mark Baum, CEO of Shrink Nanotechnologies, said: “Biotech researchers, pharmaceutical companies and universities worldwide are seeking the ‘picks’ and ‘shovels’ for this generation’s stem cell ‘gold rush’. StemDisc provides those tools to accelerate cell culturing at a lower cost compared to existing protocols.
“Our patent filing on StemDisc is a part of developing an extensive intellectual property position for a number of biomedical research technologies and tools we intend to address publicly in the near future”